---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-067081"
form_type: "8-K"
ticker: "IXHL"
cik: "0001873875"
company_name: "Incannex Healthcare Inc."
filed_at: "2026-06-10T11:30:39+00:00"
generated_at: "2026-06-10T11:35:12.930727+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Incannex receives A$6M R&D tax refund; expects another A$5.1M in 2026

## Summary
- Received A$6,039,162 under Australian Government's R&D Tax Incentive Program for FY25.
- Expects additional ~A$5.1M later in 2026, total >A$11.1M non-dilutive capital received this year.
- Non-dilutive refund strengthens balance sheet, supports clinical programs (IHL-42X, PSX-001) and share repurchase.
- CEO states refund obtained without issuing shares; company remains debt-free.

## SEC filing metadata
- accession: 0001213900-26-067081
- form_type: 8-K
- ticker: IXHL
- cik: 0001873875
- company_name: Incannex Healthcare Inc.
- filed_at: 2026-06-10T11:30:39+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1873875/000121390026067081/0001213900-26-067081-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1873875/000121390026067081/ea0293917-8k_incannex.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-067081
- JSON: https://secwatch.observer/filing/0001213900-26-067081.json
- Plain text: https://secwatch.observer/filing/0001213900-26-067081.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.